Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7010
+0.0400 (6.05%)
At close: Sep 8, 2025, 4:00 PM
0.6850
-0.0160 (-2.28%)
After-hours: Sep 8, 2025, 5:40 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $88.54 million as of September 8, 2025. Its market cap has decreased by -70.21% in one year.
Market Cap
88.54M
Enterprise Value
-35.05M
1-Year Change
-70.21%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $88.54M, a decrease of -24.35%. That is a compound annual growth rate of -6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 83.49M | -60.42% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | 117.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |